A lot of people complain about large institutional investors causing swings or manipulating the share price however this is one of the times we retail investors have an advantage. We know for certain that the pricing for ryoncil announced today was not factored into the share price, no one predicted it. Institutional investors are not able to make sudden and rash decisions based on an announcement made 1hr prior to trading and will instead have to factor the announced price into their algorithms to forecast appropriate vaulations etc. As a result, be thankful for the opportunity to buy shares at a substantial discount. The chart still looks excellent and has pulled back on pretty light volume. We will be breaking the recent top @$3.37 very shortly and plenty of price sensitive news to come (hypoplastic LHS, crohns/UC, heart failure etc)
MSB Price at posting:
$2.46 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)